Glucagon-like peptide-1 receptor agonists, also known as GLP-1 analogs, GLP-1RAs, or incretin mimetics, are a class of anorectic drugs that reduce blood sugar and energy intake by activating the GLP-1 receptor. From Wikipedia
Research from Dublin highlights the potential of GLP-1 receptor agonists to reduce alcohol cravings, though larger trials are needed to confirm findings.
